A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth
Cancer Letters · 2026-06 · 648 · 218463
DOI: 10.1016/j.canlet.2026.218463 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-06. Verfasst von Yao-Tsung Tsai und 12 weiteren Autor:innen. Beteiligte Einrichtung: International Ph.D. Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan; The Ph.D…. Die Arbeit nennt 16 Literaturangaben. Gefördert von: National Science and Technology Council, Ministry of Education, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- International Ph.D. Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan; The Ph.D. Program for Translational Medicine, College of Medical Science and T…
- Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- Division of Gastroenterology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical Univers…
- Ji Yan Biomedical (JY BioMed) Co., Ltd, Taipei, Taiwan.
- Ji Yan Biomedical (JY BioMed) Co., Ltd, Taipei, Taiwan; Division of Clinical Cariology and Endodontology, Department of Oral Rehabilitation, School of Dentistry, Health Sciences University of Hokkaido, Hokkaido, Japan.
- Ji Yan Biomedical (JY BioMed) Co., Ltd, Taipei, Taiwan; Division of Clinical Cariology and Endodontology, Department of Oral Rehabilitation, School of Dentistry, Health Sciences University of Hokkaido, Hokkaido, Japan;…
Förderung
- National Science and Technology Council
- Ministry of Education
- Ministry of Science and Technology, Taiwan
- National Health Research Institutes
Zitieren
APA
Tsai, Y. T., Yen, M. H., Hu, P. J., Lee, C. C., Liu, C. Y., Cheng, T. M., Shen, H. T., Benjamin Zhang, B. X., Lee, H. L., Chuang, K. H., Yap, C. V., Wang, W. C., & Wu, M. H. (2026). A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth. Cancer Letters, 648, 218463. https://doi.org/10.1016/j.canlet.2026.218463
Vancouver
Tsai YT, Yen MH, Hu PJ, Lee CC, Liu CY, Cheng TM, et al. A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth. Cancer Letters. 2026;648:218463. doi:10.1016/j.canlet.2026.218463
BibTeX
@article{Tsai2026,
author = {Tsai, Yao-Tsung and Yen, Min-Hsuan and Hu, Ping-Jen and Lee, Cheng-Chung and Liu, Chang-Yi and Cheng, Tsai-Mu and Shen, Hsieh-Tsung and Benjamin Zhang, Bo-Xiang and Lee, Hsin-Lun and Chuang, Kuo-Hsiang and Yap, Chee-Voon and Wang, Wen-Chang and Wu, Ming-Heng},
title = {A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth},
journal = {Cancer Letters},
year = {2026},
volume = {648},
pages = {218463},
doi = {10.1016/j.canlet.2026.218463}
}
EUVIMED